Literature DB >> 27317026

Comparative study of the neurotoxicological effects of tramadol and tapentadol in SH-SY5Y cells.

Juliana Faria1, Joana Barbosa2, Odília Queirós3, Roxana Moreira3, Félix Carvalho4, Ricardo Jorge Dinis-Oliveira5.   

Abstract

Opioid therapy and abuse are increasing, justifying the need to study their toxicity and underlying mechanisms. Given opioid pharmacodynamics at the central nervous system, the analysis of toxic effects in neuronal models gains particular relevance. The aim of this study was to compare the toxicological effects of acute exposure to tramadol and tapentadol in the undifferentiated human SH-SY5Y neuroblastoma cell line. Upon exposure to tramadol and tapentadol concentrations up to 600μM, cell toxicity was assessed through evaluation of oxidative stress, mitochondrial and metabolic alterations, as well as cell viability and death mechanisms through necrosis or apoptosis, and related signalling. Tapentadol was observed to trigger much more prominent toxic effects than tramadol, ultimately leading to energy deficit and cell death. Cell death was shown to predominantly occur through necrosis, with no alterations in membrane potential or in cytochrome c release. Both drugs were shown to stimulate glucose uptake and to cause ATP depletion, due to changes in the expression of energy metabolism enzymes. The toxicity mechanisms in such a neuronal model are relevant to understand adverse reactions to these opioids and to contribute to dose adjustment in order to avoid neurological damage.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Bioenergetics; In vitro; Neurotoxicity; Tapentadol; Tramadol

Mesh:

Substances:

Year:  2016        PMID: 27317026     DOI: 10.1016/j.tox.2016.06.010

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  7 in total

1.  Shining a Light on the Effects of the Combination of (-)-Epigallocatechin-3-gallate and Tapentadol on the Growth of Human Triple-negative Breast Cancer Cells.

Authors:  Sabrina Bimonte; Marco Cascella; Antonio Barbieri; Claudio Arra; Arturo Cuomo
Journal:  In Vivo       Date:  2019 Sep-Oct       Impact factor: 2.155

2.  Tramadol ameliorates behavioural, biochemical, mitochondrial and histological alterations in ICV-STZ-induced sporadic dementia of Alzheimer's type in rats.

Authors:  Dinesh K Dhull; Anil Kumar
Journal:  Inflammopharmacology       Date:  2017-12-16       Impact factor: 4.473

3.  Evaluation of mitochondrial dysfunction due to oxidative stress in therapeutic, toxic and lethal concentrations of tramadol.

Authors:  Leila Mohammadnejad; Kambiz Soltaninejad; Mohammad Seyedabadi; Seyed Khosro Ghasem Pouri; Mohammad Shokrzadeh; Hamidreza Mohammadi
Journal:  Toxicol Res (Camb)       Date:  2021-11-08       Impact factor: 3.524

4.  Co-occurrence of preconception maternal childhood adversity and opioid use during pregnancy: Implications for offspring brain development.

Authors:  Madeleine C Allen; Nora K Moog; Claudia Buss; Elizabeth Yen; Hanna C Gustafsson; Elinor L Sullivan; Alice M Graham
Journal:  Neurotoxicol Teratol       Date:  2021-09-30       Impact factor: 4.071

5.  The Impact of CXCR4 Blockade on the Survival of Rat Brain Cortical Neurons.

Authors:  José Joaquín Merino; Alba Garcimartín; María Elvira López-Oliva; Juana Benedí; María Pilar González
Journal:  Int J Mol Sci       Date:  2016-11-30       Impact factor: 5.923

6.  Human Neuronal Cell Lines as An In Vitro Toxicological Tool for the Evaluation of Novel Psychoactive Substances.

Authors:  Valeria Sogos; Paola Caria; Clara Porcedda; Rafaela Mostallino; Franca Piras; Cristina Miliano; Maria Antonietta De Luca; M Paola Castelli
Journal:  Int J Mol Sci       Date:  2021-06-24       Impact factor: 5.923

7.  Effects of rapamycin and curcumin on inflammation and oxidative stress in vitro and in vivo - in search of potential anti-epileptogenic strategies for temporal lobe epilepsy.

Authors:  C M Drion; J van Scheppingen; A Arena; K W Geijtenbeek; L Kooijman; E A van Vliet; E Aronica; J A Gorter
Journal:  J Neuroinflammation       Date:  2018-07-23       Impact factor: 8.322

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.